Natriuretic Peptide Testing in Heart Failure
Key result
A 75-year-old woman with multiple comorbidities presented with worsening dyspnea and an NT-proBNP level of 5500 pg/mL, raising the question of acutely decompensated heart failure.
Why the study?
Does this patient have acutely decompensated heart failure (ADHF)?
Population
A 75-year-old woman with morbid obesity, coronary artery disease, chronic obstructive pulmonary disease, and…
Design
Case_report
Authors
Discussion
Loading...
Member takes
Implication
NT-proBNP elevation warrants cautious interpretation amid CKD/COPD; case reports leave open validated adjunctive criteria for ADHF diagnosis.
Study Design
Type
Case Report (n=1)
Structured PICO
Does this patient have acutely decompensated heart failure (ADHF)?
P
Population
A 75-year-old woman with multiple comorbidities including morbid obesity, CAD, COPD, and CKD presenting with worsening dyspnea and elevated NT-proBNP.
E
Exposure
Aminoterminal pro-B-type natriuretic peptide (NT-proBNP) testing
O
Outcome
Diagnosis of acutely decompensated heart failure (ADHF)
This clinical vignette highlights the diagnostic challenge of interpreting elevated NT-proBNP levels in a dyspneic patient with multiple confounding comorbidities such as CKD and COPD.
Cite This Study
Kim et al. (2011) conducted a case report in Worsening dyspnea / suspected acutely decompensated heart failure (n=1). NT-proBNP testing was evaluated on Acutely decompensated heart failure (ADHF) diagnosis. A 75-year-old woman with multiple comorbidities presented with worsening dyspnea and an NT-proBNP level of 5500 pg/mL, raising the question of acutely decompensated heart failure.